WCN26-6522 Primary Hyperoxaluria Type 1 Diagnosed at End-Stage Kidney Disease Following Recurrent Urolithiasis: A Case Report Highlighting the Challenges of Transplant Planning

Read full text Summarise with VIRAT
Authors: Chika Shibuya, Sumi Hidaka, Yasuhiro Mochida, Mizuki Yamano, Kunihiro Ishioka, Machiko Oka, Kyoko Maesato, Yusuke Tsukamoto, Takayasu Ohtake, Shuzo Kobayashi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disorder caused by hepatic alanine-glyoxylate aminotransferase (AGXT) deficiency. This defect leads to overproduction of endogenous oxalate, resulting in recurrent kidney stones, nephrocalcinosis, and eventually kidney failure. After stage 3 CKD, systemic oxalate accumulation, often reaching kilograms quantities, occurs primarily in the skeleton and other organs. However, many patients unfortunately, receive a diagnosis only after progressing to end-stage kidney disease (ESKD).

Fields of Study & Subjects

Kidney Stones and Urolithiasis Treatments Metabolism and Genetic Disorders Parathyroid Disorders and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106140–106140
Publication date
25 March 2026
Language
EN